311 related articles for article (PubMed ID: 15109585)
1. Treatment of depression in Parkinson's disease.
Sawabini KA; Watts RL
Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S37-41. PubMed ID: 15109585
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor agonists and depression in Parkinson's disease.
Picillo M; Rocco M; Barone P
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S81-4. PubMed ID: 20123564
[TBL] [Abstract][Full Text] [Related]
3. A matter of motion or an emotional matter? Management of depression in Parkinson's disease.
Lagopoulos J; Malhi GS; Ivanovski B; Cahill CM; Morris JG
Expert Rev Neurother; 2005 Nov; 5(6):803-10. PubMed ID: 16274337
[TBL] [Abstract][Full Text] [Related]
4. Depressive symptoms in Parkinson's disease.
Lemke MR
Eur J Neurol; 2008 Apr; 15 Suppl 1():21-5. PubMed ID: 18353133
[TBL] [Abstract][Full Text] [Related]
5. Depression in Parkinson's disease: identification and management.
Chen JJ; Marsh L
Pharmacotherapy; 2013 Sep; 33(9):972-83. PubMed ID: 23798003
[TBL] [Abstract][Full Text] [Related]
6. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
[TBL] [Abstract][Full Text] [Related]
7. Depression in Parkinson's disease: conceptual issues and clinical challenges.
Leentjens AF
J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):120-6. PubMed ID: 15312275
[TBL] [Abstract][Full Text] [Related]
8. Importance of treatment of depression in assuring the most efficacious management of Parkinson's disease.
Kaiser HE; Bodey B; Bodey B
In Vivo; 2000; 14(3):457-62. PubMed ID: 10904882
[TBL] [Abstract][Full Text] [Related]
9. [Benchmarking in patient care: depression in Parkinson's disease].
Spottke A; Schneider F; Dodel R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):383-8. PubMed ID: 21767798
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol-induced catalepsy: a model for screening antidepressants effective in treatment of depression with Parkinson's disease.
Khisti RT; Mandhane SN; Chopde CT
Indian J Exp Biol; 1997 Dec; 35(12):1297-301. PubMed ID: 9567763
[TBL] [Abstract][Full Text] [Related]
11. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
Devos D; Dujardin K; Poirot I; Moreau C; Cottencin O; Thomas P; Destée A; Bordet R; Defebvre L
Mov Disord; 2008 Apr; 23(6):850-7. PubMed ID: 18311826
[TBL] [Abstract][Full Text] [Related]
12. Depression in Parkinson's disease: impediments to recognition and treatment options.
Poewe W; Luginger E
Neurology; 1999; 52(7 Suppl 3):S2-6. PubMed ID: 10227602
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease: diagnosis and treatment.
Rao SS; Hofmann LA; Shakil A
Am Fam Physician; 2006 Dec; 74(12):2046-54. PubMed ID: 17186710
[TBL] [Abstract][Full Text] [Related]
14. [Depression and Parkinson's Disease: study of a series of 135 Parkinson's patients].
Anguenot A; Loll PY; Neau JP; Ingrand P; Gil R
Can J Neurol Sci; 2002 May; 29(2):139-46. PubMed ID: 12038469
[TBL] [Abstract][Full Text] [Related]
15. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
16. Treatment of behavioural symptoms and dementia in Parkinson's disease.
Hanagasi HA; Emre M
Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
[TBL] [Abstract][Full Text] [Related]
17. The neuropsychiatry of Parkinson's disease.
Lauterbach EC
Minerva Med; 2005 Jun; 96(3):155-73. PubMed ID: 16175159
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial interventions for depression and anxiety in Parkinson's disease.
Yang S; Sajatovic M; Walter BL
J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):113-21. PubMed ID: 22689704
[TBL] [Abstract][Full Text] [Related]
19. Nonmotor manifestations of Parkinson's disease.
Simuni T; Sethi K
Ann Neurol; 2008 Dec; 64 Suppl 2():S65-80. PubMed ID: 19127582
[TBL] [Abstract][Full Text] [Related]
20. New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease.
Goetz CG
Mov Disord; 2010; 25 Suppl 1():S104-9. PubMed ID: 20187250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
